2133 related articles for article (PubMed ID: 26658811)
1. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
2. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
3. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
[TBL] [Abstract][Full Text] [Related]
4. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
5. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.
Kuerten S; Angelov DN
Ann Anat; 2008; 190(1):1-15. PubMed ID: 18342137
[TBL] [Abstract][Full Text] [Related]
6. MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.
Kuerten S; Kostova-Bales DA; Frenzel LP; Tigno JT; Tary-Lehmann M; Angelov DN; Lehmann PV
J Neuroimmunol; 2007 Sep; 189(1-2):31-40. PubMed ID: 17655940
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
8. The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Gruppe TL; Recks MS; Addicks K; Kuerten S
Histol Histopathol; 2012 Sep; 27(9):1163-74. PubMed ID: 22806903
[TBL] [Abstract][Full Text] [Related]
9. Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.
Kuerten S; Gruppe TL; Laurentius LM; Kirch C; Tary-Lehmann M; Lehmann PV; Addicks K
APMIS; 2011 Jun; 119(6):336-46. PubMed ID: 21569091
[TBL] [Abstract][Full Text] [Related]
10. Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
Soellner IA; Rabe J; Mauri V; Kaufmann J; Addicks K; Kuerten S
Clin Immunol; 2013 Dec; 149(3):519-29. PubMed ID: 24239839
[TBL] [Abstract][Full Text] [Related]
11. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
12. Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
Recks MS; Grether NB; van der Broeck F; Ganscher A; Wagner N; Henke E; Ergün S; Schroeter M; Kuerten S
Clin Immunol; 2015 Jul; 159(1):93-106. PubMed ID: 25959684
[TBL] [Abstract][Full Text] [Related]
13. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
Simon M; Ipek R; Homola GA; Rovituso DM; Schampel A; Kleinschnitz C; Kuerten S
J Neuroinflammation; 2018 Aug; 15(1):225. PubMed ID: 30098594
[TBL] [Abstract][Full Text] [Related]
15. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
Wang C; Gold BG; Kaler LJ; Yu X; Afentoulis ME; Burrows GG; Vandenbark AA; Bourdette DN; Offner H
J Neurochem; 2006 Sep; 98(6):1817-27. PubMed ID: 16899071
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histological findings in proteolipid protein-induced experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens.
Chalk JB; McCombe PA; Smith R; Pender MP
J Neurol Sci; 1994 May; 123(1-2):154-61. PubMed ID: 7520480
[TBL] [Abstract][Full Text] [Related]
19. Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?
Tsunoda I; Tanaka T; Terry EJ; Fujinami RS
Am J Pathol; 2007 Jan; 170(1):214-26. PubMed ID: 17200195
[TBL] [Abstract][Full Text] [Related]
20. Delineating the impact of neuroantigen vs genetic diversity on MP4-induced EAE of C57BL/6 and B6.129 mice.
Kuerten S; Rodi M; Javeri S; Gruppe TL; Tary-Lehmann M; Lehmann PV; Addicks K
APMIS; 2009 Dec; 117(12):923-35. PubMed ID: 20078558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
